PlainRecalls
FDA Drug Low Class III Terminated

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01

Reported: February 10, 2021 Initiated: January 21, 2021 #D-0247-2021

Product Description

Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01

Reason for Recall

Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.

Details

Units Affected
46,479 bottles
Distribution
Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 46,479 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 10, 2021. Severity: Low. Recall number: D-0247-2021.